Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07STB
|
|||
| Drug Name |
EG-1962
|
|||
| Indication | Aneurysmal subarachnoid hemorrhage [ICD-11: 8B01.0] | Phase 3 | [1] | |
| Subarachnoid hemorrhage [ICD-11: 8B01] | Phase 3 | [2], [3], [4] | ||
| Company |
Edge Therapeutics Berkeley Heights, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02790632) Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage (NEWTON2). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.